ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.

William W T Aye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.